{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:50:39Z","timestamp":1791489039198,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-026-01206-w","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:36:59Z","timestamp":1787593019000},"page":"824-830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From guidelines to practice: antihypertensive prescribing preferences in T\u00fcrkiye\u2014the APP-T\u00fcrkiye study"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2541-255X","authenticated-orcid":false,"given":"Sukru","family":"Ulusoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-3911","authenticated-orcid":false,"given":"Gulsum","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Aykut","family":"Fidanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suayip","family":"Birinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"1206_CR1","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"1206_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"CK Chow","year":"2013","unstructured":"Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. PURE (Prospective Urban Rural Epidemiology) study investigators. prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959\u201368.","journal-title":"JAMA"},{"key":"1206_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","volume":"389","author":"3-NCD Risk Factor Collaboration","year":"2017","unstructured":"3-NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37\u201355.","journal-title":"Lancet"},{"key":"1206_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"4-NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","unstructured":"4-NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","journal-title":"Lancet"},{"key":"1206_CR5","first-page":"13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, et al. ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high BP in adults: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:13\u2013115.","journal-title":"Hypertension"},{"key":"1206_CR6","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension: endorsed by the international society of hypertension (ISH) and the European renal association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"1206_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-5-21","volume":"5","author":"A Fretheim","year":"2005","unstructured":"Fretheim A, Oxman AD. International variation in prescribing antihypertensive drugs: its extent and possible explanations. BMC Health Serv Res. 2005;5:21.","journal-title":"BMC Health Serv Res"},{"key":"1206_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/HJH.0000000000000901","volume":"34","author":"S Sengul","year":"2016","unstructured":"Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Turkish society of hypertension and renal diseases. changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34:1208\u201317.","journal-title":"J Hypertens"},{"key":"1206_CR9","unstructured":"Turkish Statistical Institute (TurkStat). Address Based Population Registration System, 2023. Available at: https:\/\/nip.tuik.gov.tr\/. Accessed 15 January 2025."},{"key":"1206_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1010539520965280","volume":"33","author":"V Arshad","year":"2021","unstructured":"Arshad V, Samad Z, Das J, Almas A, Rashid N, Virani SS, et al. Prescribing patterns of antihypertensive medications in low- and middle-income countries: a systematic review. Asia Pac J Public Health. 2021;33:14\u201322.","journal-title":"Asia Pac J Public Health"},{"key":"1206_CR11","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/CIRCULATIONAHA.118.033360","volume":"138","author":"G Bai","year":"2018","unstructured":"Bai G, Bennet C, Wang J, Anderson GF. Access to antihypertensive drugs in China. Circulation. 2018;138:1777\u20139.","journal-title":"Circulation"},{"key":"1206_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/10641963.2018.1465074","volume":"41","author":"T Ishida","year":"2019","unstructured":"Ishida T, Oh A, Hiroi S, Shimasaki Y, Tsuchihashi T. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities. Clin Exp Hypertens. 2019;41:203\u201310.","journal-title":"Clin Exp Hypertens"},{"key":"1206_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/08037051003802541","volume":"19","author":"Y Erdem","year":"2010","unstructured":"Erdem Y, Arici M, Altun B, Turgan C, Sindel S, Erbay B, et al. The relationship between hypertension and salt intake in Turkish population: SALTURK study. Blood Press. 2010;19:313\u20138.","journal-title":"Blood Press"},{"key":"1206_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/nu9090933","volume":"9","author":"Y Erdem","year":"2017","unstructured":"Erdem Y, Akpolat T, Derici \u00dc, \u015eeng\u00fcl \u015e, Ert\u00fcrk \u015e, Ulusoy \u015e, et al. Dietary sources of high sodium intake in Turkey: SALTURK II. Nutrients. 2017;9:933.","journal-title":"Nutrients"},{"key":"1206_CR15","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated BP and hypertension. Eur Heart J. 2024;45:3912\u20134018.","journal-title":"Eur Heart J"},{"key":"1206_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3399\/bjgp20X708053","volume":"70","author":"NR Jones","year":"2020","unstructured":"Jones NR, McCormack T, Constanti M, McManus RJ. Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract. 2020;70:90\u20131.","journal-title":"Br J Gen Pract"},{"key":"1206_CR17","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/HYPERTENSIONAHA.123.21369","volume":"81","author":"M Nishimoto","year":"2024","unstructured":"Nishimoto M, Griffin KA, Wynne BM, Fujita T. Salt-sensitive hypertension and the kidney. Hypertension. 2024;81:1206\u201317.","journal-title":"Hypertension"},{"key":"1206_CR18","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A Randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103\u201316.","journal-title":"N Engl J Med"},{"key":"1206_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","volume":"293","author":"JT Wright Jr","year":"2005","unstructured":"Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293:1595\u2013608.","journal-title":"JAMA"},{"key":"1206_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1751-7176.2008.00015.x","volume":"10","author":"WC Cushman","year":"2008","unstructured":"Cushman WC, Ford CE, Einhorn PT, Wright JT Jr, Preston RA, Davis, et al. BP control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2008;10:751\u201360.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1206_CR21","first-page":"341","volume":"101","author":"DK Smith","year":"2020","unstructured":"Smith DK, Lennon RP, Carlsgaard PB. Managing hypertension using combination therapy. Am Fam Physician. 2020;101:341\u20139.","journal-title":"Am Fam Physician"},{"key":"1206_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","volume":"78","author":"R Chen","year":"2021","unstructured":"Chen R, Suchard MA, Krumholz HM, Schuemie MJ, Shea S, Duke J, et al. Comparative first-line effectiveness and safety of ACE (Angiotensin-Converting Enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension. 2021;78:591\u2013603.","journal-title":"Hypertension"},{"key":"1206_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40842-025-00268-y","volume":"12","author":"P Joshi","year":"2026","unstructured":"Joshi P, Rick G, Mesineni S, Bohara S, Atif S, Poonthottam N, et al. Antihypertensive therapy in diabetes mellitus: efficacy, safety, and metabolic impacts in type 1 and type 2 diabetes. Cardiovasc Diabetol Endocrinol Rep. 2026;12:4.","journal-title":"Cardiovasc Diabetol Endocrinol Rep"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01206-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:02:43Z","timestamp":1791486163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01206-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1206"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01206-w","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. This study was conducted using anonymized data provided by the Turkish Ministry of Health and was approved by the Turkish Ministry of Health (Approval No. 46048792-903.99-E). As the study was based on anonymized secondary data obtained through the Ministry of Health, individual informed consent was not required in accordance with the applicable national regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}